9 min read
The First CRISPR Cure: How Gene Editing Finally Kept Its Promise
In 2023, regulators approved Casgevy — the first CRISPR therapy to cure a genetic disease in humans. For people with sickle cell disease, it means a life without pain crises. Here's how a bacterial immune system became medicine.